Online Exclusives

Online Exclusives

Novo Nordisk Halts Concizumab Trials After Thrombotic Events

After observing blood clots in some patients enrolled in clinical trials of concizumab, Novo Nordisk has paused one mid-stage and two late-stage studies of...

Scientists Scour FDA-Approved Drugs for Potential Coronavirus Treatment

As part of a working group spread across 22 laboratories, a team of scientists at the University of California, San Francisco (UCSF)–based Quantitative Biosciences...

Limited Access to Recovered Patients’ Blood Slows Development of COVID-19 Antibody Drug

To develop treatments for COVID-19 (coronavirus), scientists need recovered patients’ blood samples, which they can analyze to identify and clone the most powerful antibodies...

FDA Recommends Switching to Virtual Visits in Clinical Trials

The FDA has recommended switching clinical trial protocols from in-person monitoring to virtual patient visits to help slow the spread of COVID-19. The agency...

Oncologists and Patients Navigate Treatment Decisions Amid COVID-19 Pandemic

Oncologists and patients are looking for guidance regarding cancer treatment during the COVID-19 (coronavirus) pandemic. In their coronavirus FAQs, the American Society of Clinical...

What Do Data-Sharing Deals Mean for Patient Privacy?

A growing number of U.S. hospitals are making confidential data-sharing deals with Amazon, Google, and Microsoft, which typically involve moving patient health data into...

Federal Probe Into China Ties at U.S. Institutions May Affect Blameless Researchers

As part of an ongoing investigation into foreign influence on U.S.-funded medical research by federal officials, the National Institutes of Health (NIH) has sent...

Trump’s Plan to Import Canadian Drugs Faces Continuing Opposition

Drug companies, pharmacists, and Canadians continue to push back against the Trump administration’s plan to allow states to import cheaper drugs from Canada. While several...

COVID-19 Causes U.S. Lab Closures

As U.S. institutions and universities shut down due to the coronavirus pandemic, researchers are pausing noncritical lab activities for the coming weeks. Tufts University and...

How COVID-19 Is Affecting the U.S. Pharmaceutical Supply

The COVID-19 (coronavirus) outbreak is expected to cause shortages of prescription drugs and other supplies in the U.S. as a result of shipping delays...
Advertisement

Current Issue

April 2020, Volume 6, Issue 5

This issue examines current immunization guidelines in the context of patients with hematologic disorders experiencing secondary immunodeficiency, and more.